Home

gliotransmitters

Gliotransmitters are signaling molecules released by glial cells that influence neuronal activity and synaptic transmission. In the concept of the tripartite synapse, astrocytes, a type of glial cell, actively participate in synaptic signaling by releasing gliotransmitters in response to neuronal activity. The term encompasses several chemically distinct messengers, most notably glutamate, D-serine, glycine, ATP, and GABA, among others. Astrocytic gliotransmitter release can occur via calcium-dependent exocytosis of vesicles, as well as through non-vesicular pathways such as transporter reversal, hemichannels formed by connexins, and pannexin channels. Microglia and, to a lesser extent, oligodendrocytes are also reported to release gliotransmitters, contributing to the signaling environment.

Gliotransmitters act on neuronal receptors including NMDA, AMPA, metabotropic glutamate receptors, purinergic P2X/P2Y receptors, and GABA

Dysregulation of gliotransmission has been associated with pathological conditions such as epilepsy, chronic pain, neurodegenerative diseases,

receptors,
thereby
modulating
synaptic
transmission,
timing,
and
plasticity.
They
participate
in
synaptic
scaling
and
homeostatic
regulation,
and
can
influence
neurovascular
coupling
and
cerebral
blood
flow.
They
have
been
implicated
in
sleep
regulation,
learning,
and
memory
processes.
and
neuroinflammation.
However,
the
physiological
significance
and
in
vivo
mechanisms
remain
active
areas
of
research,
with
ongoing
debates
about
the
relative
abundance
and
conditions
under
which
gliotransmission
dominates
neuronal
signaling.